scholarly article | Q13442814 |
P356 | DOI | 10.1046/J.1365-3024.1997.D01-211.X |
P698 | PubMed publication ID | 9278946 |
P50 | author | David W Dunne | Q30513910 |
Padraic G. Fallon | Q42944857 | ||
P2093 | author name string | M Webster | |
J H Ouma | |||
A E Butterworth | |||
G Kimani | |||
A J Fulford | |||
P433 | issue | 7 | |
P921 | main subject | praziquantel | Q424145 |
oxamniquine | Q682497 | ||
Schistosoma mansoni | Q2324689 | ||
P304 | page(s) | 333-335 | |
P577 | publication date | 1997-07-01 | |
P1433 | published in | Parasite Immunology | Q15751559 |
P1476 | title | Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm | |
P478 | volume | 19 |
Q34038437 | Analysis of the effects of treatment of human Schistosoma mansoni infection on the immune response of patients from endemic areas |
Q44021869 | Antibody isotype responses to Schistosoma japonicum antigens in subjects from a schistosomiasis area with repeated praziquantel chemotherapy compared with a new endemic zone in Hunan Province, P.R. China |
Q39177940 | Antibody isotype responses, infection and re-infection for Schistosoma japonicum in a marshland area of China |
Q35088439 | Association of Schistosoma mansoni-specific IgG and IgE antibody production and clinical schistosomiasis status in a rural area of Minas Gerais, Brazil |
Q62486477 | Benefits of annual chemotherapeutic control of schistosomiasis on the development of protective immunity |
Q34760480 | Chemotherapy for schistosomiasis in Ugandan fishermen: treatment can cause a rapid increase in interleukin-5 levels in plasma but decreased levels of eosinophilia and worm-specific immunoglobulin E |
Q44091869 | Down-regulation of specific antigen-driven cytokine production in a population with endemic Schistosoma japonicum infection |
Q53697118 | Effect of four rounds of annual school-wide mass praziquantel treatment for schistosoma mansoni control on schistosome-specific immune responses. |
Q36506153 | Effects of treatment on IgE responses against parasite allergen-like proteins and immunity to reinfection in childhood schistosome and hookworm coinfections |
Q34601522 | Eosinophil activity in Schistosoma mansoni infections in vivo and in vitro in relation to plasma cytokine profile pre- and posttreatment with praziquantel |
Q38887560 | Hepatosplenic schistosomiasis: playing hide-and-seek with an elusive parasite |
Q43901475 | Heterogeneities in anti-schistosome humoral responses following chemotherapy |
Q45243644 | Human IgE response to the Schistosoma haematobium 22.6 kDa antigen. |
Q38887383 | Human IgE responses to rSm22.6 are associated with infection intensity rather than age per se, in a recently established focus of Schistomiasis mansoni |
Q33245126 | Human antibody responses of patients living in endemic areas for schistosomiasis to the tegumental protein Sm29 identified through genomic studies. |
Q33965354 | Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni |
Q21092289 | Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni |
Q37994231 | Parasite glycans and antibody-mediated immune responses in Schistosoma infection |
Q24646962 | Pilot-scale production and characterization of paramyosin, a vaccine candidate for schistosomiasis japonica |
Q31920496 | Role of adult worm antigen-specific immunoglobulin E in acquired immunity to Schistosoma mansoni infection in baboons |
Q40279125 | Schistosome immunology: more questions than answers |
Q35938440 | Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infection |
Q28547483 | Single Versus Double Dose Praziquantel Comparison on Efficacy and Schistosoma mansoni Re-Infection in Preschool-Age Children in Uganda: A Randomized Controlled Trial |
Q43756314 | The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection |
Search more.